多中心德国上市后研究中选择性上气道刺激治疗阻塞性睡眠呼吸暂停的结局
这项德国三中心前瞻性单臂上市后研究纳入60例符合植入标准的阻塞性睡眠呼吸暂停患者,评估选择性舌下神经刺激的安全性和疗效。术后6个月系统平均使用时间为42.9±11.9小时/周,呼吸暂停低通气指数中位数从28.6次/小时显著降至8.3次/小时,无患者需手术修正植入系统。作者认为该疗法安全有效,是阻塞性睡眠呼吸暂停手术治疗的有力选择。
要点
- 术后6个月呼吸暂停低通气指数中位数从28.6次/小时降至8.3次/小时。
- 系统平均使用时间为42.9±11.9小时/周,所有受试者报告睡眠和日间症状改善。
- 无患者需手术修正植入系统,作者认为该疗法安全有效。
核心结论
- 选择性上气道刺激是阻塞性睡眠呼吸暂停患者安全有效的疗法,是手术治疗的有力选择。
研究设计与样本
- 前瞻性单臂上市后研究,在德国慕尼黑、曼海姆、吕贝克3家三级医院开展。
- 2014年7月至2015年10月共纳入60例接受选择性上气道刺激植入的患者,纳入标准为呼吸暂停低通气指数≥15次/小时且≤65次/小时、体重指数<35 kg/m2。
- 术前及术后6个月各行2晚家庭睡眠检测,收集安全性和疗效数据。
主要发现
- 所有受试者均报告睡眠和日间症状改善。
- 系统平均使用时间为42.9±11.9小时/周。
- 术后6个月呼吸暂停低通气指数中位数从28.6次/小时显著降至8.3次/小时(原文未报告P值)。
- 无患者需手术修正植入系统。
关键数值与推荐
- 纳入标准:呼吸暂停低通气指数≥15次/小时且≤65次/小时,体重指数<35 kg/m2。
临床怎么用
- 原文结论认为选择性上气道刺激是阻塞性睡眠呼吸暂停安全有效的疗法,是手术治疗的有力选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective Selective stimulation of the hypoglossal nerve is a new surgical therapy for obstructive sleep apnea, with proven efficacy in well-designed clinical trials. The aim of the study is to obtain additional safety and efficacy data on the use of selective upper airway stimulation during daily clinical routine. Study Design Prospective single-arm study. Setting Three tertiary hospitals in Germany (Munich, Mannheim, Lübeck). Subjects and Methods A multicenter prospective single-arm study under a common implant and follow-up protocol took place in 3 German centers (Mannheim, Munich, Lübeck). Every patient who received an implant of selective upper airway stimulation was included in this trial (apnea-hypopnea index ≥15/h and ≤65/h and body mass index <35 kg/m2). Before and 6 months after surgery, a 2-night home sleep test was performed. Data regarding the safety and efficacy were collected. Results From July 2014 through October 2015, 60 patients were included. Every subject reported improvement in sleep and daytime symptoms. The average usage time of the system was 42.9 ± 11.9 h/wk. The median apnea-hypopnea index was significantly reduced at 6 months from 28.6/h to 8.3/h. No patient required surgical revision of the implanted system. Conclusion Selective upper airway stimulation is a safe and effective therapy for patients with obstructive sleep apnea and represents a powerful option for its surgical treatment.
引用
- Heiser C, Maurer JT, Hofauer B, et al. Outcomes of Upper Airway Stimulation for Obstructive Sleep Apnea in a Multicenter German Postmarket Study. Otolaryngol Head Neck Surg. 2016. PMID: 28025918. doi:10.1177/0194599816683378
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。